Synthetic Stem Cells Market

[55 Pages Pages] The market size for synthetic stem cells is expected to grow from USD 14 million in 2023 to USD 37 million by 2028, at a CAGR of 22.5% during the forecast period. The study involved four major activities in estimating the current market size for synthetic stem cells. Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. The top-down approach was employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the size of the segments and subsegments of the market.

Secondary Research

In the secondary research process, various secondary sources such as Hoovers, Bloomberg BusinessWeek, Forbes, and Dun & Bradstreet were referred to, to identify and collect information useful for this technical, market-oriented, and commercial study of the synthetic stem cells industry. These secondary sources included annual reports, press releases & investor presentations of companies; white papers; certified publications; articles by recognized authors; gold standard & silver standard websites; food safety organizations; regulatory bodies; trade directories; and databases. Secondary research was mainly used to obtain key information about the industry’s supply chain, the total pool of key players, market classification, and segmentation, according to the industry trends to the bottom-most level and regional markets. It was also used to obtain information about the key developments from a market-oriented perspective.

Primary Research

In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the synthetic stem cells market. The primary sources from the demand side include scientists/researchers from academic & research institutes and government & private laboratories.

After the market engineering process was completed (which includes calculations for market statistics, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also conducted to identify the market segmentation; and key market dynamics such as drivers, restraints, opportunities, challenges, and industry trends. Given below is the breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down approach was used to estimate and validate the total size of the synthetic stem cells market. The approach was also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

• Synthetic stem cells that could be used as therapy were identified through secondary research, and their market shares in the respective segments were determined through primary and secondary research.
• The procedure included extensive interviews with industry leaders such as CEOs, VPs, directors, and marketing executives for key insights.
• All percentage shares, splits, and breakdowns were determined using secondary sources and are verified through primary sources.
• All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
• The above-mentioned data is consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.  

Data Triangulation

After arriving at the overall market size from the market size estimation process explained above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedure was employed, wherever applicable. Data was triangulated by studying various factors and trends from industry experts.

Report Objectives

• To define, describe, and forecast the synthetic stem cells market based on application and region
• To provide detailed information about factors influencing the market growth (drivers, restraints, opportunities, and industry-specific challenges)
• To analyze micromarkets with respect to individual growth trends, prospects, and contribution to the overall market
• To analyze market opportunities for stakeholders
• To forecast the size of the market segments in North America, Europe, Asia Pacific, and the Rest of the World (RoW)

Want to explore hidden markets that can drive new revenue in Synthetic Stem Cells Market?

Unlock Insights

Scope of the Report

This research report categorizes the synthetic stem cells market based on application and region.

On the basis of application, the synthetic stem cells market is segmented as follows:

• Cardiovascular Diseases
• Neurological Disorders
• Other Applications (Cancer, diabetes, infections, musculoskeletal disorders, gastrointestinal disorders, and ocular disorders)

On the basis of region, the synthetic stem cell market is segmented as follows:

• North America
• Europe
• Asia Pacific
• RoW

Available Customizations

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

The following customization options are available for the report:

Regional Analysis

• Further breakdown of the Europe countries (UK, Germany, France, etc.) in the synthetic stem cell market

The market size for synthetic stem cells is expected to grow from USD 14 million in 2023 to USD 37 million by 2028, at a CAGR of 22.5% during the forecast period. The ethical concerns on the use of embryonic stem cells and the risk of tumor formation and immune response to natural stem cells are the key factors driving the growth of this market.

By application, the cardiovascular diseases segment accounted for the largest share during the forecast period.

The major applications of synthetic stem cells include cardiovascular diseases, neurological disorders, and other diseases that require regenerative therapy. Cardiovascular diseases have high prevalence across the globe. Currently, synthetic mesenchymal cells have been developed only for cardiac tissue and have been tested in mice models. The research on cardiac synthetic stem cells is expected to enter the clinical phase in the coming 2-3 years, and the first commercial product would be cardiac synthetic stem cells in the next five years.

North America is expected to account for the largest market share during the forecast period.

North America is estimated to account for the largest share of the market in 2023. This is majorly attributed to the rising research on stem cells in the region, coupled with public-private funding. The region is a global leader in the research on regenerative therapies such as stem cells and is backed by funding on advanced research infrastructure to commercialize novel regenerative therapies. Moreover, North America is the pioneer of synthetic stem cell technology and will be the early adopter of this technology in the coming years.

Key Market Players

The technology is developed and patented by North Carolina State University (NCSU) (US) and Zhengzhou University (China).

Key questions addressed by the report:

• What is synthetic stem cell technology?
• What could be the future of this technology in the coming years?
• What are the regional growth trends and the largest revenue-generating regions for synthetic stem cells?
• What are the major applications of synthetic stem cells?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst